Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.

Christoph Muus | Malte D Luecken | Gökcen Eraslan | Lisa Sikkema | Avinash Waghray | Graham Heimberg | Yoshihiko Kobayashi | Eeshit Dhaval Vaishnav | Ayshwarya Subramanian | Christopher Smillie | Karthik A Jagadeesh | Elizabeth Thu Duong | Evgenij Fiskin | Elena Torlai Triglia | Meshal Ansari | Peiwen Cai | Brian Lin | Justin Buchanan | Sijia Chen | Jian Shu | Adam L Haber | Hattie Chung | Daniel T Montoro | Taylor Adams | Hananeh Aliee | Samuel J Allon | Zaneta Andrusivova | Ilias Angelidis | Orr Ashenberg | Kevin Bassler | Christophe Bécavin | Inbal Benhar | Joseph Bergenstråhle | Ludvig Bergenstråhle | Liam Bolt | Emelie Braun | Linh T Bui | Steven Callori | Mark Chaffin | Evgeny Chichelnitskiy | Joshua Chiou | Thomas M Conlon | Michael S Cuoco | Anna S E Cuomo | Marie Deprez | Grant Duclos | Denise Fine | David S Fischer | Shila Ghazanfar | Astrid Gillich | Bruno Giotti | Joshua Gould | Minzhe Guo | Austin J Gutierrez | Arun C Habermann | Tyler Harvey | Peng He | Xiaomeng Hou | Lijuan Hu | Yan Hu | Alok Jaiswal | Lu Ji | Peiyong Jiang | Theodoros S Kapellos | Christin S Kuo | Ludvig Larsson | Michael A Leney-Greene | Kyungtae Lim | Monika Litviňuková | Leif S Ludwig | Soeren Lukassen | Wendy Luo | Henrike Maatz | Elo Madissoon | Lira Mamanova | Kasidet Manakongtreecheep | Sylvie Leroy | Christoph H Mayr | Ian M Mbano | Alexi M McAdams | Ahmad N Nabhan | Sarah K Nyquist | Lolita Penland | Olivier B Poirion | Sergio Poli | CanCan Qi | Rachel Queen | Daniel Reichart | Ivan Rosas | Jonas C Schupp | Conor V Shea | Xingyi Shi | Rahul Sinha | Rene V Sit | Kamil Slowikowski | Michal Slyper | Neal P Smith | Alex Sountoulidis | Maximilian Strunz | Travis B Sullivan | Dawei Sun | Carlos Talavera-López | Peng Tan | Jessica Tantivit | Kyle J Travaglini | Nathan R Tucker | Katherine A Vernon | Marc H Wadsworth | Julia Waldman | Xiuting Wang | Ke Xu | Wenjun Yan | William Zhao | Carly G K Ziegler | NHLBI LungMap Consortium | Human Cell Atlas Lung Biological Network
Nature medicine | 2021

Angiotensin-converting enzyme 2 (ACE2) and accessory proteases (TMPRSS2 and CTSL) are needed for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cellular entry, and their expression may shed light on viral tropism and impact across the body. We assessed the cell-type-specific expression of ACE2, TMPRSS2 and CTSL across 107 single-cell RNA-sequencing studies from different tissues. ACE2, TMPRSS2 and CTSL are coexpressed in specific subsets of respiratory epithelial cells in the nasal passages, airways and alveoli, and in cells from other organs associated with coronavirus disease 2019 (COVID-19) transmission or pathology. We performed a meta-analysis of 31 lung single-cell RNA-sequencing studies with 1,320,896 cells from 377 nasal, airway and lung parenchyma samples from 228 individuals. This revealed cell-type-specific associations of age, sex and smoking with expression levels of ACE2, TMPRSS2 and CTSL. Expression of entry factors increased with age and in males, including in airway secretory cells and alveolar type 2 cells. Expression programs shared by ACE2+TMPRSS2+ cells in nasal, lung and gut tissues included genes that may mediate viral entry, key immune functions and epithelial-macrophage cross-talk, such as genes involved in the interleukin-6, interleukin-1, tumor necrosis factor and complement pathways. Cell-type-specific expression patterns may contribute to the pathogenesis of COVID-19, and our work highlights putative molecular pathways for therapeutic intervention.

Pubmed ID: 33654293 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL127349
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK043351
  • Agency: Medical Research Council, United Kingdom
    Id: MR/S035907/1
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL148867
  • Agency: Medical Research Council, United Kingdom
    Id: MR/S035826/1
  • Agency: Medical Research Council, United Kingdom
    Id: MR/P009581/1
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL130938
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL145567
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL145550
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL148861
  • Agency: NHLBI NIH HHS, United States
    Id: F32 HL149290
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL141380
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL119215
  • Agency: NHLBI NIH HHS, United States
    Id: K08 HL130595
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL148856
  • Agency: NIDDK NIH HHS, United States
    Id: RC2 DK114784
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI116482
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL145372
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL122700
  • Agency: NIA NIH HHS, United States
    Id: P01 AG049665
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007753
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK117263
  • Agency: NHLBI NIH HHS, United States
    Id: K08 HL146943
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI135964
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL080494
  • Agency: NICHD NIH HHS, United States
    Id: R24 HD000836
  • Agency: NHLBI NIH HHS, United States
    Id: R35 HL140039
  • Agency: Medical Research Council, United Kingdom
    Id: MR/S005579/1
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL146519
  • Agency: Wellcome Trust, United Kingdom
  • Agency: NIAID NIH HHS, United States
    Id: U24 AI118672
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL133153
  • Agency: British Heart Foundation, United Kingdom
    Id: SP/19/1/34461
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL146557
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI142784
  • Agency: NHLBI NIH HHS, United States
    Id: R56 HL135124

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


National Disease Research Interchange (tool)

RRID:SCR_000550

NDRI is a Not-For-Profit (501c3) Corporation dedicated to providing the highest quality human biomaterials for research. NDRI makes it easy for researchers to get the human tissues and organs they need, prepared, preserved and shipped precisely according to their specific scientific protocols, as quickly as possible, and in the largest available quantities. NDRI provides researchers with protocol specific human neurological tissues such as brain stem, spinal cord, and basal ganglia, among others. In addition to control specimens, NDRI recovers tissues from donors with a variety of diseases, including Down syndrome, Parkinsons disease, Alzheimers disease, schizophrenia, and dementia. Through the NDRI 24/7 referral and procurement system, research consented biospecimens can be provided from low post mortem interval donors preserved at 4ºC, frozen or snap frozen, fixed, paraffin embedded, or as unstained slides.

View all literature mentions